Deficient 17 -Hydroxysteroid Dehydrogenase Type 2 Expression in Endometriosis: Failure to Metabolize 17 -Estradiol
article
OA: closed
CC0
⤵ 69 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper investigated the expression of 17-hydroxysteroid dehydrogenase type 2 in endometriosis, finding a deficiency that impairs the metabolism of 17-estradiol.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (50)
- Letrozole plus metformin versus letrozole alone in the treatment of symptomatic endometrioma 2025
- Endometriosis and ovulatory menstruation: beyond the Sampson principle 2025
- Efficacy of melatonin and letrozole combination therapy compared to letrozole alone in the treatment of symptomatic endometrioma in infertile women 2025
- Inhibitory effects of estetrol on the invasion and migration of immortalized human endometrial stromal cells 2023
- Is intracrinology of endometriosis relevant in clinical practice? A systematic review on estrogen metabolism 2022
- Progesterone Resistance in Endometriosis 2022
- Papel de MICA na endometriose 2022
- Ovarian reserve in women with endometriosis under total cystectomy compared to partial cystectomy: A randomized clinical trial 2021
- The role of mitogen‐activated protein kinase signaling pathway in endometriosis 2021
- The Ethanol Extract of Avocado (<i>Persea americana</i> Mill. (Lauraceae)) Seeds Successfully Induces Implant Regression and Restores Ovarian Dynamic in a Rat Model of Endometriosis 2020
- Estrogen is an important mediator of mast cell activation in ovarian endometriomas 2017
- Molecular Biology of Endometriosis 2016
- Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics 2016
- Dienogest reduces HSD17β1 expression and activity in endometriosis 2015
- Endometriosis‐Associated Ovarian Cancer 2014
- Inducing malignant transformation of endometriosis in rats by long‐term sustaining hyperestrogenemia and type <scp>II</scp> diabetes 2014
- Endometriosis and Infertility 2012
- Endometriosis: a premenopausal disease? Age pattern in 42,079 patients with endometriosis 2012
- Endometriosis and Infertility 2012
- Effects of progestins on local estradiol biosynthesis and action in the Z-12 endometriotic epithelial cell line 2012
- Effect of mifepristone on COX-2 both in eutopic and ectopic endometrium in mouse endometriotic model 2012
- Progestin effects on expression of AKR1C1–AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line 2012
- Uterine Peristalsis and the Development of Endometriosis and Adenomyosis 2011
- Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis 2011
- Is There A Relationship between Polycystic Ovary Syndrome and Endometriosis? 2011
- Die Pathophysiologie von Endometriose und Adenomyose. Morphologische, funktionelle und molekularbiologische Grundlagen 2011
- A new concept of endometriosis and adenomyosis: tissue injury and repair (TIAR) 2011
- Regulatory T cells and other leukocytes in the pathogenesis of endometriosis 2011
- Estrogen biosynthesis and signaling in endometriosis 2011
- Aberrant DNA methylation status of endometriosis: Epigenetics as the pathogenesis, biomarker and therapeutic target 2011
- Inhibition of steroid sulfatase decreases endometriosis in an in vivo murine model 2011
- Theories on the Pathogenesis of Endometriosis 2011
- Role of Steroid Hormones: Estrogen and Endometriosis 2011
- Pelvic Mechanisms Involved in the Pathophysiology of Pain in Endometriosis 2011
- Different progestins in the treatment of endometriosis – are there relevant differences? 2010
- Recent advances on the action of estrogens and progestogens in normal and pathological human endometrium 2010
- Attachment to extracellular matrices is enhanced in human endometriotic stromal cells: a possible mechanism underlying the pathogenesis of endometriosis 2010
- Comparison of aromatase inhibitor (letrozole) and immunomodulators (infliximab and etanercept) on the regression of endometriotic implants in a rat model 2010
- Endometriosis 2009
- The non-human primate model of endometriosis: research and implications for fecundity 2009
- Endometriosis 2009
- The place of dydrogesterone in the treatment of endometriosis and adenomyosis 2009
- Reoperation for Endometriosis and Ovarian Remnants 2009
- REVIEW ARTICLE: Three‐Dimensional Culture of Endometrial Cells: An <i>In Vitro</i> Model of Endometriosis 2008
- Angiogenesis and antiangiogenic therapy in endometriosis 2007
- Small primary adenocarcinoma in adenomyosis with nodal metastasis: a case report 2007
- Dysmenorrhea in Adolescents and Young Adults: Etiology and Management 2006
- Endometriosis as a model for inflammation–hormone interactions in ovarian and breast cancers 2006
- Endometriosis: New Genetic Approaches and Therapy 2005
- Aromatase inhibitors and cyclooxygenase-2 (COX-2) inhibitors in endometriosis: New questions—old answers? 2005
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- unpaywall
- last seen: 2026-08-23T06:29:45.520198+00:00
License: CC0
· commercial use OK